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Background
The effect of polar organic xenobiotics in the central
nervous system depends on blood-brain barrier (BBB)
penetration of these compounds. Newly synthesized
pyridinium aldoximes (K-compounds) are promising
antidotes for organophosphate intoxications. However,
being highly polar, their BBB penetration is question-
able. Using an in vivo model we aimed to characterize
the BBB penetration of K-compounds.
Methods
Male Wistar rats were injected intramuscularly with var-
ious doses of pyridinium aldoximes, blood, cerebrospinal
fluid (CSF), and brain samples were collected after 5, 15,
30, 60 and 180 min. A recently developed and optimized
RP-HPLC method was used for analysis. Samples of brain
homogenate, blood serum and CSF were subjected to
clean-up using precipitation by perchloric acid (pH < 1)
and centrifugation at 14,000 rpm at 4°C for 20 min. Before
load onto Zorbax Rx-C18 stationary phase, the pH of the
supernatants was adjusted to 2. As mobile phase a mixture
of acetonitrile and aqueous buffer pH 4.5, also containing
ion-pairing agent, was used.
Results
Dose- and time-dependent BBB penetration of pyridi-
nium aldoximes was experimentally found.
Conclusions
Dose- and time-dependent brain and CSF levels of these
highly polar K-compounds following intramuscular
administration suggest contribution of active transport
or specific transporters in their BBB penetration. The
BBB transport may also depend on the size and charge
of the solutes.
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